Skip to main content

Table 2 Baseline patient characteristics

From: Prognostic value of DCE-CT-derived blood volume and flow compared to core biopsy microvessel density in patients with metastatic renal cell carcinoma

 

CD34-indexT

 

Above median (>), n (%)

Below median (≤), n (%)

p-value

Total

12

13

 

Age (years)

  

0.543

 > Median (57.2)

5 (41.7)

7 (58.3)

 

 ≤ Median (57.2)

7 (53.8)

6 (46.2)

 

Sex

  

0.225

 Male

10 (55.6)

8 (44.4)

 

 Female

2 (28.6)

5 (71.4)

 

Treatment group

  

0.848

 IL2/ IFN-α

6 (46.2)

7 (53.8)

 

 IL2/INF-α/bevacizumab

6 (50.0)

6 (50.0)

 

IMDC category

  

0.152

 Favourable

2 (100.0)

-

 

 Intermediate

9 (50.0)

9 (50.0)

 

 Poor

1 (20.0)

4 (80.0)

 

Target lesion volume (cm3)

  

0.848

 > Median (44.9)

6 (46.2)

7 (53.8)

 

 ≤ Median (44.9)

6 (50.0)

6 (50.0)

 

Synchronous metastases

  

0.378

 Yes

8 (42.1)

11 (57.9)

 

 No

4 (66.7)

2 (33.3)

 
  1. CD34-indexT CD34-index in the tumour outline, IMDC International Metastatic Renal Cell Carcinoma Database Consortium, IFN-α Interferon alpha, IL-2 Interleukin-2